Cargando…
Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein
BACKGROUND: To investigate the ability of rESAT6 to identify different mycobacteria-sensitized guinea pigs and its safety in preclinical and phase I clinical study. MATERIAL/METHODS: Guinea pigs were sensitized with different Mycobacteria. After sensitization, all animals were intradermally injected...
Autores principales: | Du, Wei-Xin, Chen, Bao-Wen, Lu, Jin-Biao, Gao, Meng-Qiu, Shen, Xiao-Bing, Yang, Lei, Su, Cheng, Wang, Guo-Zhi, Sun, Qing-feng, Xu, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659126/ https://www.ncbi.nlm.nih.gov/pubmed/23676766 http://dx.doi.org/10.12659/MSMBR.883912 |
Ejemplares similares
-
Efficacy and safety of recombinant Mycobacterium tuberculosis ESAT-6 protein for diagnosis of pulmonary tuberculosis: A phase II trial
por: Sun, Qing-Feng, et al.
Publicado: (2013) -
A novel recombinant DNA vaccine encoding Mycobacterium tuberculosis ESAT-6 and FL protects against Mycobacterium tuberculosis challenge in mice
por: Jiang, Qingtao, et al.
Publicado: (2013) -
Macrophage Immune Response Suppression by Recombinant Mycobacterium tuberculosis Antigens, the ESAT-6, CFP-10, and ESAT-6/CFP-10 Fusion Proteins
por: Seghatoleslam, Atefeh, et al.
Publicado: (2016) -
Author Correction: A novel recombinant DNA vaccine encoding
Mycobacterium tuberculosis ESAT-6 and FL protects against
Mycobacterium tuberculosis challenge in mice
por: Jiang, Qingtao, et al.
Publicado: (2022) -
Expression and Purification of Recombinant Mycobacterium Tuberculosis (TB) Antigens, ESAT-6, CFP-10 and ESAT- 6/CFP-10 and Their Diagnosis Potential for Detection of TB Patients
por: Hemmati, M, et al.
Publicado: (2011)